Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Por Burge, R. T., Disch, D. P., Gelwicks, S., Zhang, X., Krege, J. H.
Publicado no Osteoporos Int (2016)

PINP as a biological response marker during teriparatide treatment for osteoporosis

Por Krege, J. H., Lane, N. E., Harris, J. M., Miller, P. D.
Publicado em 2014

Teriparatide for osteoporosis: importance of the full course

Por Lindsay, R., Krege, J. H., Marin, F., Jin, L., Stepan, J. J.
Publicado no Osteoporos Int (2016)

Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.

Por Davisson, R L, Kim, H S, Krege, J H, Lager, D J, Smithies, O, Sigmund, C D
Publicado em 1997

Genetic control of blood pressure and the angiotensinogen locus.

Por Kim, H S, Krege, J H, Kluckman, K D, Hagaman, J R, Hodgin, J B, Best, C F, Jennette, J C, Coffman, T M, Maeda, N, Smithies, O
Publicado em 1995